The present invention relates to the new use of 1,2-bridged 1,4-dihydropyridines which are known in some cases, of the general formula (I) ##STR1## in which R.sup.1 to R.sup.4 and a have the meaning indicated in the description, processes for their preparation and their use as medicaments, as selective potassium channel modulators, in particular for the treatment of the central nervous system.
本发明涉及已知的1,2-桥联1,4-
二氢吡啶的新用途,其具有以下一般式(I):##STR1##其中R.sup.1至R.sup.4和a在说明中所示,以及它们的制备过程和它们作为药物的用途,作为选择性
钾通道调节剂,特别是用于治疗中枢神经系统。